Frank Litvack - Director at Capricor Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
CAPR on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Frank Litvack since 10/6/2023

Holdings reported by Frank Litvack for Capricor Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 133K $185K $1.39 Aug 14, 2023 Direct
Stock Option (Right to Buy) 200K Jan 2, 2024 Direct Common Stock

Transactions reported by Frank Litvack for Capricor Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.